Molecular Systems BiologySystems BiologyPeer-reviewed journal article
Identification of Covalent Modifications Regulating Immune Signaling Complex Composition and Phenotype
Annika Frauenstein, Stefan EbneriD, Fynn M. HanseniD, Ankit SinhaiD, Kshiti Meera Phulphagar, Kirby N. SwatekiD, Daniel HornburgiD, Matthias ManniD, Felix MeissneriD
Abstract
Cells signal through rearrangements of protein communities governed by covalent modifications and reversible interactions of distinct sets of proteins. A method that identifies those post-transcriptional modifications regulating signaling complex composition and functional phenotypes in one experimental setup would facilitate an efficient identification of novel molecular signaling checkpoints. Here we devised Modifications, Interactions and Phenotypes by Affinity Purification Mass Spectrometry (MIP-APMS), comprising the streamlined cloning and transduction of tagged proteins into functionalized reporter cells as well as affinity chromatography, followed by MS-based quantification. We report the time-resolved interplay of more than 50 previously undescribed modification and hundreds of protein-protein interactions of 19 immune protein complexes in monocytes. Validation of interdependecies between covalent, reversible and functional protein complex regulations by knock-out or site-specific mutation, revealed isgylation and phosphorylation of TRAF2 as well as ARHGEF18 interaction in Toll-like receptor 2 signaling. Moreover, we identify distinct mechanisms of action for small molecule inhibitors of p-38 (MAPK14). Our method provides a fast and cost-effective pipeline for the molecular interrogation of protein communities in diverse biological systems and primary cells. HighlightsO_LIExperimental framework to reveal dynamic signaling checkpoints in primary cells C_LIO_LIIdentification of crosstalk between protein modifications and interactions in signaling complexes C_LIO_LIDiscovery of TRAF2 isgylation, phosphorylation and ARHGEF18 interaction in monocytes C_LIO_LIDifferential drug mode of action for p-38 (MAPK14) kinase inhibitors C_LI Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=131 SRC="FIGDIR/small/384750v1_ufig1.gif" ALT="Figure 1"> View larger version (55K): org.highwire.dtl.DTLVardef@1e833d3org.highwire.dtl.DTLVardef@1a2805forg.highwire.dtl.DTLVardef@199e1eaorg.highwire.dtl.DTLVardef@1becf99_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- assay: proteomics
- research focus: cell type annotation
- research focus: differential expression
- research focus: protein structure prediction
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 7
- FWCI
- 0.55
- Field percentile
- top 48%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- An Atlas of Protein Phosphorylation Dynamics During Interferon Signaling
Idoia Busnadiego, Marie Lork, … Benjamin G. Hale·Proceedings of the National Academy of SciencesPeer-reviewed·Mar 26, 2025
- A scalable proteogenomic framework for dissecting phospho-signaling pathways in primary immune cells
Christian Michel Beusch, Carolyn Morningstar, … David Ezra Gordon·bioRxiv·Oct 8, 2025
- Cap-related modifications of RNA regulate binding to IFIT proteins
Jingping Geng, Magdalena Chrabąszczewska, … Renata Grzela·RNAPeer-reviewed·Jul 15, 2024
- Quantitative Cell Proteomic Atlas: Pathway-scale targeted mass spectrometry for high-resolution functional profiling of cell signaling
P. Cifani, A. Kentsis·bioRxiv·Apr 14, 2022
- Protein interaction network analysis of mTOR signaling reveals modular organization
Devin T. Wehle, Carter S. Bass, … Stephen E.P. Smith·Journal of Biological ChemistryPeer-reviewed·Sep 21, 2023
- The CC′ loop of IgV domain containing immune checkpoint receptors: From a bystander to an active determinant of receptor:ligand binding
S. V. Kundapura, U. A. Ramagopal·bioRxiv·May 31, 2019